92 related articles for article (PubMed ID: 8094978)
21. Fine structure genetic analysis of a beta-globin promoter.
Myers RM; Tilly K; Maniatis T
Science; 1986 May; 232(4750):613-8. PubMed ID: 3457470
[TBL] [Abstract][Full Text] [Related]
22. Correct usage of multiple transcription initiation sites and C/EBP-dependent transcription activation of the rat XDH/XO TATA-less promoter requires downstream elements located in the coding region of the gene.
Clark MP; Chow CW; Rinaldo JE; Chalkley R
Nucleic Acids Res; 1998 Apr; 26(7):1801-6. PubMed ID: 9512555
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of the adenovirus 2 IVa2 initiator and downstream elements.
Chen H; Flint SJ
J Biol Chem; 1992 Dec; 267(35):25457-65. PubMed ID: 1460040
[TBL] [Abstract][Full Text] [Related]
24. Mammalian multidrug-resistance gene: correlation of exon organization with structural domains and duplication of an ancestral gene.
Raymond M; Gros P
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6488-92. PubMed ID: 2570420
[TBL] [Abstract][Full Text] [Related]
25. Efficient transcription of an immunoglobulin kappa promoter requires specific sequence elements overlapping with and downstream of the transcriptional start site.
Pelletier MR; Hatada EN; Scholz G; Scheidereit C
Nucleic Acids Res; 1997 Oct; 25(20):3995-4003. PubMed ID: 9321649
[TBL] [Abstract][Full Text] [Related]
26. The c-myc protein represses the lambda 5 and TdT initiators.
Mai S; Mårtensson IL
Nucleic Acids Res; 1995 Jan; 23(1):1-9. PubMed ID: 7870572
[TBL] [Abstract][Full Text] [Related]
27. Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells.
Hsu SI; Cohen D; Kirschner LS; Lothstein L; Hartstein M; Horwitz SB
Mol Cell Biol; 1990 Jul; 10(7):3596-606. PubMed ID: 1972547
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the imperfect octamer-containing human immunoglobulin VH6 gene promoter.
Sun Z; Kitchingman GR
Nucleic Acids Res; 1994 Mar; 22(5):850-60. PubMed ID: 8139927
[TBL] [Abstract][Full Text] [Related]
29. Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene.
Ueda K; Pastan I; Gottesman MM
J Biol Chem; 1987 Dec; 262(36):17432-6. PubMed ID: 2891692
[TBL] [Abstract][Full Text] [Related]
30. Identification and functional characterization of the human and murine polo-like kinase (Plk) promoter.
Bräuninger A; Strebhardt K; Rübsamen-Waigmann H
Oncogene; 1995 Nov; 11(9):1793-800. PubMed ID: 7478607
[TBL] [Abstract][Full Text] [Related]
31. Involvement of protein kinase in environmental stress-induced activation of human multidrug resistance 1 (MDR1) gene promoter.
Uchiumi T; Kohno K; Tanimura H; Hidaka K; Asakuno K; Abe H; Uchida Y; Kuwano M
FEBS Lett; 1993 Jul; 326(1-3):11-6. PubMed ID: 8100781
[TBL] [Abstract][Full Text] [Related]
32. Cloning and promoter analysis of the human B-50/GAP-43 gene.
de Groen PC; Eggen BJ; Gispen WH; Schotman P; Schrama LH
J Mol Neurosci; 1995; 6(2):109-19. PubMed ID: 8746449
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional control elements of the rat thymidylate synthase promoter: evolutionary conservation of regulatory features.
Lee Y; Johnson LF
Exp Cell Res; 2000 Jul; 258(1):53-64. PubMed ID: 10912787
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the promoter region of the human MDR3 P-glycoprotein gene.
Smit JJ; Mol CA; van Deemter L; Wagenaar E; Schinkel AH; Borst P
Biochim Biophys Acta; 1995 Mar; 1261(1):44-56. PubMed ID: 7893760
[TBL] [Abstract][Full Text] [Related]
35. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents.
Kohno K; Sato S; Takano H; Matsuo K; Kuwano M
Biochem Biophys Res Commun; 1989 Dec; 165(3):1415-21. PubMed ID: 2575381
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional regulation of the human CD3 gamma gene: the TATA-less CD3 gamma promoter functions via an initiator and contiguous Sp-binding elements.
Badran BM; Kunstman K; Stanton J; Moschitta M; Zerghe A; Akl H; Burny A; Wolinsky SM; Willard-Gallo KE
J Immunol; 2005 May; 174(10):6238-49. PubMed ID: 15879122
[TBL] [Abstract][Full Text] [Related]
37. An Inr-containing sequence flanking the TATA box of the human c-sis (PDGF-B) proto-oncogene promoter functions in cis as a co-activator for its intronic enhancer.
Franklin GC; Adam GI; Miller SJ; Moncrieff CL; Ullerås E; Ohlsson R
Oncogene; 1995 Nov; 11(9):1873-84. PubMed ID: 7478617
[TBL] [Abstract][Full Text] [Related]
38. Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance.
Azzaria M; Schurr E; Gros P
Mol Cell Biol; 1989 Dec; 9(12):5289-97. PubMed ID: 2573836
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the human Megalin/LRP-2 promoter in vitro and in primary parathyroid cells.
Knutson A; Hellman P; Akerström G; Westin G
DNA Cell Biol; 1998 Jun; 17(6):551-60. PubMed ID: 9655248
[TBL] [Abstract][Full Text] [Related]
40. Purification and characterization of NF-R2 that regulates the expression of the human multidrug resistance (MDR1) gene.
Takatori T; Ogura M; Tsuruo T
Jpn J Cancer Res; 1993 Mar; 84(3):298-303. PubMed ID: 8098026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
